Drug Profile
CI 1012
Alternative Names: PD 159206Latest Information Update: 25 Sep 2021
Price :
$50
*
At a glance
- Originator Pfizer
- Developer National Institutes of Health (USA); Pfizer
- Class Antivirals; Benzamides
- Mechanism of Action HIV zinc finger inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued HIV infections
Most Recent Events
- 29 Dec 1998 Discontinued-II for HIV infections treatment in USA (PO)
- 05 Mar 1997 Phase-II clinical trials for HIV infections treatment in USA (PO)
- 08 Aug 1996 New profile